Activity Downloads

To Participate

To participate in this continuing education activity:

1. Review the activity description and objectives.
2. View the activity.
3. Complete the online post-test and activity evaluation.

View the other Modules in this CSPE Core Curriculum Series:
  
Fertility Module #1: Introduction to Infertility for the Specialty Health Care Pharmacist ►

Fertility Module #2: Infertility: Therapeutics and Medication Profiles ►

Fertility Module #4: Infertility: Special Populations and Considerations ►

 

A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education (CSPE)

 
 View more NASP/CSPE Activities ►

Activity Description

Infertility is a disease of the reproductive system. It is defined for most couples as not being able to get pregnant or maintain a pregnancy despite having frequent, unprotected, appropriately timed intercourse for at least a year. It is estimated that during their primary reproductive years, that 10 to 15 percent of couples in the United States are infertile. This condition affects both women and men. It is believed that almost 7 million women and 4 million men are affected by infertility.

Module 3 reviews the appropriate pharmacological and non-pharmacological protocols typically used to address infertility. The medications used in a typical assisted reproductive therapy course will also be presented. The patient monitoring of these agents will also be discussed.

Learning Objectives

The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:

• Identify monitoring parameters for a patient undergoing treatment for infertility
• Discuss the different commonly used medication protocols used in an ART cycle
• Discuss recommended appropriate pharmacologic plans to address infertility

Faculty

Ann Scalia, BSN, RN, CNOR
Manager- Clinical Education Specialists
Walgreens

Mary Vietzke, BSN, RN
Senior Clinical Educational Specialist
Walgreens

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Ann Scalia and Mary Vietzke are employees of Walgreens.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 03-24-2017
Expiration Date: 03-24-2019

Pharmacists

This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-090-H01-P has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

No external support has been received for this activity.

 

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Download Handout